{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:08:05Z","timestamp":1770296885244,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaapos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.jaapos.2006.07.001","type":"journal-article","created":{"date-parts":[[2006,10,26]],"date-time":"2006-10-26T07:31:57Z","timestamp":1161847917000},"page":"464-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Additive Effect of Topical Dorzolamide and Systemic Acetazolamide in Pediatric Glaucoma"],"prefix":"10.1016","volume":"10","author":[{"given":"Kourosh","family":"Sabri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex V.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaapos.2006.07.001_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9394(54)92027-9","article-title":"Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, Diamox; a preliminary report","volume":"37","author":"Becker","year":"1954","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaapos.2006.07.001_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archopht.1954.00920050335001","article-title":"Carbonic anhydrase inhibitor acetazoleamide (Diamox); a new approach to the therapy of glaucoma","volume":"52","author":"Breinin","year":"1954","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2006.07.001_bib3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archopht.1954.00920040745001","article-title":"Diamox (acetazoleamide) in treatment of glaucoma","volume":"51","author":"Grant","year":"1954","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2006.07.001_bib4","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0161-6420(91)32295-4","article-title":"MK-507 versus sezolamide","volume":"98","author":"Lippa","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2006.07.001_bib5","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archopht.1995.01100080061030","article-title":"A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol","volume":"113","author":"Strahlman","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2006.07.001_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/112067210001000105","article-title":"A topical or oral carbonic anhydrase inhibitor to control ocular hypertension after cataract surgery","volume":"10","author":"Abbasoglu","year":"2000","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jaapos.2006.07.001_bib7","first-page":"344","article-title":"A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification surgery","volume":"43","author":"Zohdy","year":"1998","journal-title":"J R Coll Surg Edinb"},{"key":"10.1016\/j.jaapos.2006.07.001_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0161-6420(98)91421-X","article-title":"Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation","volume":"105","author":"Rosenberg","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2006.07.001_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1006\/phrs.1997.0167","article-title":"Comparative effects of intraocular pressure between systemic and topical carbonic anhydrase inhibitors: a clinical masked, cross-over study","volume":"35","author":"Centofanti","year":"1997","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jaapos.2006.07.001_bib10","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/archopht.1997.01100160411003","article-title":"Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy","volume":"115","author":"Ladas","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2006.07.001_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1034\/j.1600-0420.1998.760618.x","article-title":"A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol","volume":"76","author":"Hutzelmann","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jaapos.2006.07.001_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1091-8531(98)90109-4","article-title":"Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma","volume":"2","author":"Portellos","year":"1998","journal-title":"J AAPOS"},{"key":"10.1016\/j.jaapos.2006.07.001_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archopht.1997.01100150047008","article-title":"Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans","volume":"115","author":"Maus","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2006.07.001_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archopht.116.1.19","article-title":"Aqueous humor flow in human eyes treated with dorzolamide and different doses of acetazolamide","volume":"116","author":"Larsson","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2006.07.001_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00061198-200406000-00006","article-title":"Effects on aqueous flow of dorzolamide combined with either timolol or acetazolamide","volume":"13","author":"Toris","year":"2004","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jaapos.2006.07.001_bib16","doi-asserted-by":"crossref","unstructured":"Miller WH, Dessert AM, Roblin RO. Heterocyctic sulfonamide as carbonic anhydrase inhibitors. J Am Chem Soc 72:4893.","DOI":"10.1021\/ja01167a012"},{"key":"10.1016\/j.jaapos.2006.07.001_bib17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0014-4835(85)90177-0","article-title":"Age-related changes in carbonic anhydrase of toad lens","volume":"41","author":"Skipski","year":"1985","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jaapos.2006.07.001_bib18","first-page":"323","article-title":"Neurochemical findings in the aging brain","volume":"23","author":"Meier-Ruge","year":"1980","journal-title":"Adv Biochem Psychopharmacol"},{"key":"10.1016\/j.jaapos.2006.07.001_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0039-6257(97)00053-2","article-title":"Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor","volume":"42","author":"Pfeiffer","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jaapos.2006.07.001_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1350-9462(99)00006-3","article-title":"Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors","volume":"19","author":"Sugrue","year":"2000","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jaapos.2006.07.001_bib21","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0026-895X(25)13290-2","article-title":"Chemical properties of carbonic anhydrase IV, the membrane bound enzyme","volume":"44","author":"Maren","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaapos.2006.07.001_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/exer.1993.1100","article-title":"A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion","volume":"57","author":"Brechue","year":"1993","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jaapos.2006.07.001_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0887-8994(96)00228-7","article-title":"Growth suppresion in children receiving acetazolamide with antiepileptic drugs","volume":"15","author":"Futagi","year":"1996","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jaapos.2006.07.001_bib24","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/archinte.1985.00360100075012","article-title":"Significant metabolic acidosis induced by acetazolamide","volume":"145","author":"Heller","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaapos.2006.07.001_bib25","first-page":"997","article-title":"Acidosis, alkalosis, and aqueous humor dynamics in rabbits","volume":"16","author":"Krupin","year":"1977","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaapos.2006.07.001_bib26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0002-9394(85)90004-2","article-title":"Failure of acetazolamide to decrease intraocular pressure in patients with carbonic anhydrase II deficiency","volume":"99","author":"Krupin","year":"1985","journal-title":"Am J Ophthalmol"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853106004150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853106004150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:15:05Z","timestamp":1761077705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853106004150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S1091853106004150"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2006.07.001","relation":{},"ISSN":["1091-8531"],"issn-type":[{"value":"1091-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Additive Effect of Topical Dorzolamide and Systemic Acetazolamide in Pediatric Glaucoma","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2006.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}